EUVIMEDEUVIMED entdecken
Crossref

Effect of mGluR2 and mGluR2/3 activators on parkinsonism in the MPTP-lesioned non-human primate

Imane Frouni, Cynthia Kwan, Dominique Bédard, Adjia Hamadjida, Woojin Kang, Sébastien Belliveau, Stephen G Nuara, Jim C Gourdon, Philippe Huot

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024

DOI: 10.1007/s00210-024-03216-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2024. Verfasst von Imane Frouni und 8 weiteren Autor:innen. Beteiligte Einrichtung: Neurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), 3801 University St, Montreal, Quebec, H3A 2B4, Canada. Hauptthemen laut MEDLINE: Receptors, Metabotropic Glutamate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Metabotropic GlutamateAnimalsMaleAntiparkinson AgentsAmino AcidsCallithrixLevodopaParkinsonian DisordersMPTP PoisoningBridged Bicyclo Compounds, HeterocyclicFemaleMotor ActivityHypokinesiaExcitatory Amino Acid AgonistsCyclohexanesPyridinesSulfonamidesPurinesBridged Bicyclo Compounds

Stichwörter der Autor:innen

CBiPESLY-354,740LY-404,039LY-487,379MPTPMarmosetParkinsonismParkinson’s diseasemGluR2mGluR2/3

Substanzen

Receptors, Metabotropic Glutamatemetabotropic glutamate receptor 2metabotropic glutamate receptor 3Antiparkinson AgentsAmino AcidsLevodopaeglumetadN-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamineBridged Bicyclo Compounds, Heterocyclic2-amino-3-((3,4-difluorophenyl)sulfanylmethyl)-4-hydroxy-bicyclo(3.1.0)hexane-2,6-dicarboxylic acid hydrochloride

Autor:innen und Institutionen

  • Neurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), 3801 University St, Montreal, Quebec, H3A 2B4, Canada.
  • Comparative Medicine & Animal Resource Centre, McGill University, Montreal, Quebec, Canada.
  • Neurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), 3801 University St, Montreal, Quebec, H3A 2B4, Canada. philippe.huot@mcgill.ca.
  • Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada. philippe.huot@mcgill.ca.
  • Movement Disorder Clinic, Division of Neurology, Department of Neurosciences, McGill University Health Centre, Montreal, Quebec, Canada. philippe.huot@mcgill.ca.

Zitieren

APA

Frouni, I., Kwan, C., Bédard, D., Hamadjida, A., Kang, W., Belliveau, S., Nuara, S. G., Gourdon, J. C., & Huot, P. (2024). Effect of mGluR2 and mGluR2/3 activators on parkinsonism in the MPTP-lesioned non-human primate. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03216-2

Vancouver

Frouni I, Kwan C, Bédard D, Hamadjida A, Kang W, Belliveau S, et al. Effect of mGluR2 and mGluR2/3 activators on parkinsonism in the MPTP-lesioned non-human primate. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. doi:10.1007/s00210-024-03216-2

BibTeX
@article{Frouni2024,
  author = {Frouni, Imane and Kwan, Cynthia and Bédard, Dominique and Hamadjida, Adjia and Kang, Woojin and Belliveau, Sébastien and Nuara, Stephen G and Gourdon, Jim C and Huot, Philippe},
  title = {Effect of mGluR2 and mGluR2/3 activators on parkinsonism in the MPTP-lesioned non-human primate},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  doi = {10.1007/s00210-024-03216-2}
}
Kostenlos starten →